Results 81 to 90 of about 21,988 (154)

The Gap Between Practice and Guidelines in the Choice of First-line Disease Modifying Antirheumatic Drug in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort [PDF]

open access: bronze, 2009
Mathilde Benhamou   +9 more
openalex   +1 more source

Co‐prescription of low‐dose methotrexate and trimethoprim‐sulfamethoxazole and the 30‐day risk of death among older adults: A cohort study

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 4, Page 1263-1271, April 2025.
Abstract Aims The aim of this study was to characterize the risk of death in older adults co‐prescribed low‐dose methotrexate and TMP‐SMX vs. low‐dose methotrexate and a cephalosporin. Methods We conducted a retrospective, population‐based, new‐user cohort study in Ontario, Canada (April 1, 2002–August 1, 2022) using linked administrative healthcare ...
Hasti Sadeghi   +7 more
wiley   +1 more source

RESEARCH: Effects of Long‐Term Disease‐Modifying Antirheumatic Drugs on Endothelial Function in Patients with Early Rheumatoid Arthritis [PDF]

open access: bronze, 2010
M. Turiel   +9 more
openalex   +1 more source

Maternal Demographic Patterns in Medication use During Pregnancy: A Nationwide Register Study

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 136, Issue 4, April 2025.
ABSTRACT In recent years, medication use during pregnancy has increased, yet its association with maternal characteristics remains unclear. To address this gap, we aimed to investigate how maternal age, pre‐gestational body mass index (BMI), smoking, parity, ethnic origin and employment status relate to medication use during pregnancy.
Mette Østergaard Thunbo   +4 more
wiley   +1 more source

Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis: A Network Meta-Analysis.

open access: yesJAMA Netw Open, 2023
Guski LS   +6 more
europepmc   +1 more source

Disease-modifying antirheumatic drugs [PDF]

open access: bronze, 2010
Jennifer M. Belavic
openalex   +1 more source

Home - About - Disclaimer - Privacy